Drug Type Small molecule drug  | 
Synonyms-  | 
Target  | 
Action inhibitors  | 
Mechanism KRAS G12D inhibitors(GTPase KRas G12D inhibitors)  | 
Active Indication  | 
Inactive Indication-  | 
Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhasePreclinical  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | South Korea   | 22 Mar 2024 | |
| Pancreatic Cancer | Preclinical | South Korea   | 22 Mar 2024 | 





